Sonoma Pharmaceuticals
SNOA
#10114
Rank
NZ$5.78 M
Marketcap
$4.32
Share price
-4.25%
Change (1 day)
-10.51%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -NZ$6.97 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.54 Million. In 2023 the company made an earning of -NZ$7.74 Million, an increase over its 2022 earnings that were of -NZ$11.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$6.97 Million-10.06%
2023 -NZ$7.74 Million-31.5%
2022 -NZ$11.3 Million16.86%
2021 -NZ$9.67 Million194.32%
2020 -NZ$3.29 Million-58.76%
2019 -NZ$7.97 Million-65.66%
2018 -NZ$23.2 Million4.84%
2017 -NZ$22.13 Million-2.17%
2016 -NZ$22.62 Million32.12%
2015 -NZ$17.12 Million-307.74%
2014 NZ$8.23 M-197.5%
2013 -NZ$8.45 Million
2010 -NZ$13.21 Million-14.02%
2009 -NZ$15.36 Million-57.28%
2008 -NZ$35.95 Million-8.03%
2007 -NZ$39.09 Million3.85%
2006 -NZ$37.64 Million39.31%
2005 -NZ$27.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$31.66 Million 324.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 2,655.87%๐Ÿ‡บ๐Ÿ‡ธ USA